Tuesday 15th of March 2022 11:46:18 AM

AbbVie hits new 52-week high

AbbVie headquarters building facade of an American publicly traded biopharmaceutical company Michael Vi/iStock Editorial via Getty Images
  • AbbVie (ABBV +2.2%) hit a fresh 52-week high today, this time to $155.40 in Tuesday afternoon trading.
  • Not including Tuesday's gain, AbbVie (ABBV +2.2%) is up ~15% year to date.
  • Read why Seeking Alpha contributor Zvi Bar agues that AbbVie (ABBV +2.2%) is a buy.


Top gainers today
Top losers today